Canal Insurance Company Stake in Raytheon Ord (RTN) Has Lowered by $935,000 as Shares Rose; Rothschild Asset Management Has Decreased Its Celgene (CELG) Holding by $13.50 Million

May 24, 2018 - By Ash

Celgene Corporation (NASDAQ:CELG) Logo

Rothschild Asset Management Inc decreased its stake in Celgene Corp (CELG) by 27.25% based on its latest 2017Q4 regulatory filing with the SEC. Rothschild Asset Management Inc sold 129,771 shares as the company’s stock declined 19.30% with the market. The institutional investor held 346,477 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $36.16M, down from 476,248 at the end of the previous reported quarter. Rothschild Asset Management Inc who had been investing in Celgene Corp for a number of months, seems to be less bullish one the $57.95B market cap company. The stock increased 2.74% or $2.12 during the last trading session, reaching $79.79. About 6.69 million shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 24, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Canal Insurance Company decreased its stake in Raytheon Ord (RTN) by 7.14% based on its latest 2017Q4 regulatory filing with the SEC. Canal Insurance Company sold 5,000 shares as the company’s stock rose 14.84% while stock markets declined. The institutional investor held 65,000 shares of the industrial machinery and components company at the end of 2017Q4, valued at $12.21 million, down from 70,000 at the end of the previous reported quarter. Canal Insurance Company who had been investing in Raytheon Ord for a number of months, seems to be less bullish one the $61.35B market cap company. The stock increased 1.16% or $2.45 during the last trading session, reaching $213.59. About 1.04 million shares traded. Raytheon Company (NYSE:RTN) has risen 42.32% since May 24, 2017 and is uptrending. It has outperformed by 30.77% the S&P500.

More notable recent Raytheon Company (NYSE:RTN) news were published by: Seekingalpha.com which released: “Raytheon: Buy The Dip” on April 30, 2018, also Seekingalpha.com with their article: “Raytheon Company 2018 Q1 – Results – Earnings Call Slides” published on April 26, 2018, Prnewswire.com published: “Raytheon, No Barriers seek disabled veterans for transformational expedition” on May 24, 2018. More interesting news about Raytheon Company (NYSE:RTN) were released by: Seekingalpha.com and their article: “Raytheon: Think Like An Attacker” published on May 15, 2018 as well as Seekingalpha.com‘s news article titled: “Look For Broken Stocks On Tepid Market Days – Cramer’s Mad Money (5/22/18)” with publication date: May 23, 2018.

Among 21 analysts covering Raytheon Company (NYSE:RTN), 16 have Buy rating, 1 Sell and 4 Hold. Therefore 76% are positive. Raytheon Company had 81 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, August 11 by Buckingham Research. The stock of Raytheon Company (NYSE:RTN) earned “Buy” rating by Jefferies on Monday, July 24. The rating was maintained by Jefferies with “Buy” on Friday, June 23. The company was maintained on Sunday, October 8 by RBC Capital Markets. Morgan Stanley maintained the stock with “Overweight” rating in Friday, February 23 report. The stock of Raytheon Company (NYSE:RTN) earned “Buy” rating by RBC Capital Markets on Thursday, July 27. The rating was downgraded by Credit Suisse to “Neutral” on Tuesday, May 22. Deutsche Bank maintained Raytheon Company (NYSE:RTN) rating on Friday, October 28. Deutsche Bank has “Hold” rating and $145 target. As per Monday, July 17, the company rating was maintained by Cowen & Co. The rating was maintained by Deutsche Bank on Monday, December 5 with “Hold”.

Since January 2, 2018, it had 1 insider buy, and 20 sales for $31.62 million activity. 1,219 shares were bought by Paliwal Dinesh C, worth $249,895 on Monday, April 30. Another trade for 9,589 shares valued at $2.03M was sold by Kremer Wesley D. Shares for $2.12M were sold by Jimenez Frank R on Tuesday, February 13. The insider Kennedy Thomas A sold 44,778 shares worth $9.67M. 12,054 shares were sold by RHOADS REBECCA R, worth $2.56 million. WAJSGRAS DAVID C sold $2.77 million worth of Raytheon Company (NYSE:RTN) on Tuesday, February 13.

Analysts await Raytheon Company (NYSE:RTN) to report earnings on July, 26. They expect $2.31 EPS, up 16.67% or $0.33 from last year’s $1.98 per share. RTN’s profit will be $663.55M for 23.12 P/E if the $2.31 EPS becomes a reality. After $2.20 actual EPS reported by Raytheon Company for the previous quarter, Wall Street now forecasts 5.00% EPS growth.

Investors sentiment decreased to 1.09 in Q4 2017. Its down 0.12, from 1.21 in 2017Q3. It turned negative, as 36 investors sold RTN shares while 374 reduced holdings. 106 funds opened positions while 340 raised stakes. 202.53 million shares or 1.45% less from 205.51 million shares in 2017Q3 were reported. Asset Mngmt Inc invested 0.16% in Raytheon Company (NYSE:RTN). Bartlett And Communications Ltd Com has invested 0.09% of its portfolio in Raytheon Company (NYSE:RTN). Valley National Advisers accumulated 20 shares or 0% of the stock. 1,892 were accumulated by Maple Capital Management. Farmers Tru Company has invested 0.85% in Raytheon Company (NYSE:RTN). Moreover, Legacy Incorporated has 0.68% invested in Raytheon Company (NYSE:RTN) for 7,324 shares. Campbell Commerce Adviser Lc holds 1,430 shares or 0.2% of its portfolio. Old Mutual Customised Solutions (Proprietary) Ltd stated it has 5,092 shares or 0.1% of all its holdings. Mufg Americas has invested 0.07% in Raytheon Company (NYSE:RTN). Georgia-based Rowland & Counsel Adv has invested 0.04% in Raytheon Company (NYSE:RTN). Central Bank And Trust holds 0.01% in Raytheon Company (NYSE:RTN) or 148 shares. Jnba Fincl Advisors reported 50 shares. Fort Washington Inv Advisors Oh owns 15,889 shares. Moreover, Cullen Ltd Liability Corporation has 2.12% invested in Raytheon Company (NYSE:RTN) for 328,350 shares. The Washington-based Coldstream Mngmt has invested 0.03% in Raytheon Company (NYSE:RTN).

Canal Insurance Company, which manages about $280.89 million US Long portfolio, upped its stake in At&T Ord (NYSE:T) by 88,800 shares to 98,800 shares, valued at $3.84 million in 2017Q4, according to the filing. It also increased its holding in Merck & Co Ord (Prn) (NYSE:MRK) by 70,000 shares in the quarter, for a total of 110,000 shares, and has risen its stake in Royal Dutch Shell Adr Rpstg 2 A Ord.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Seekingalpha.com which released: “Will ‘Public Shaming’ Sink Celgene?” on May 21, 2018, also Seekingalpha.com with their article: “Generic Revlimid Could Sink Celgene” published on May 16, 2018, Seekingalpha.com published: “Is Celgene’s Stock A Buy The Dip Opportunity?” on May 23, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Nasdaq.com and their article: “Warren Buffett’s Mentor Was Right About the Crazy Market — and 2 Biotech Stocks Prove It” published on May 23, 2018 as well as Seekingalpha.com‘s news article titled: “Celgene’s (CELG) Management Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)” with publication date: May 16, 2018.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It turned negative, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Valley Natl Advisers holds 0.29% or 8,016 shares. Moreover, Bb Biotech Ag has 10.06% invested in Celgene Corporation (NASDAQ:CELG). Birch Hill Inv Ltd Liability Com invested 2.73% of its portfolio in Celgene Corporation (NASDAQ:CELG). Capital Planning Advisors Ltd has invested 0.14% in Celgene Corporation (NASDAQ:CELG). Veritable Limited Partnership holds 31,744 shares or 0.07% of its portfolio. Arete Wealth Lc holds 0.12% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 3,446 shares. Mathes Inc reported 2,040 shares stake. Chilton Cap Mngmt Ltd Liability stated it has 0.03% of its portfolio in Celgene Corporation (NASDAQ:CELG). Eagleclaw Managment Ltd Liability Com reported 11,910 shares stake. 39,000 are held by Bridgecreek Investment Management Ltd Liability Co. Commonwealth Of Pennsylvania Pub School Empls Retrmt invested in 70,424 shares or 0.1% of the stock. Sumitomo Life Comm holds 0.51% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 38,815 shares. Moreover, Amer Money Mgmt Ltd Llc has 1% invested in Celgene Corporation (NASDAQ:CELG). Amp Ltd stated it has 393,144 shares. Dillon Associates invested 2.04% of its portfolio in Celgene Corporation (NASDAQ:CELG).

Since February 8, 2018, it had 2 buys, and 3 sales for $3.48 million activity. MARIO ERNEST sold $1.26M worth of stock. 3,260 shares valued at $299,594 were bought by Alles Mark J on Thursday, February 8. $851,093 worth of Celgene Corporation (NASDAQ:CELG) shares were sold by LOUGHLIN JAMES J.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 26. They expect $1.87 earnings per share, up 11.31% or $0.19 from last year’s $1.68 per share. CELG’s profit will be $1.36B for 10.67 P/E if the $1.87 EPS becomes a reality. After $1.61 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts 16.15% EPS growth.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 148 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Oppenheimer given on Wednesday, June 14. SunTrust maintained it with “Buy” rating and $139.0 target in Thursday, January 25 report. The firm has “Buy” rating by RBC Capital Markets given on Tuesday, January 23. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Suntrust Robinson on Friday, April 29. The firm earned “Equal-Weight” rating on Friday, October 13 by Barclays Capital. As per Wednesday, June 7, the company rating was maintained by Oppenheimer. The firm earned “Buy” rating on Wednesday, July 26 by Mizuho. The stock of Celgene Corporation (NASDAQ:CELG) earned “Hold” rating by Piper Jaffray on Thursday, December 21. The rating was maintained by Canaccord Genuity with “Buy” on Friday, October 27. The rating was maintained by Oppenheimer on Thursday, July 27 with “Buy”.

Rothschild Asset Management Inc, which manages about $4.79B and $9.48B US Long portfolio, upped its stake in Technipfmc Plc by 161,069 shares to 525,521 shares, valued at $16.45 million in 2017Q4, according to the filing. It also increased its holding in Spx Corp (SPW) by 18,804 shares in the quarter, for a total of 1.19M shares, and has risen its stake in Newfield Expl Co (NYSE:NFX).

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Ash

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts